Answers are grounded in this paper and cite their sources.
Evaluates cytopathogenic effects of HTLV-III in HTLV-I-carrying cells, suggesting implications for AIDS research.
The human T-cell lines MT-2 and MT-4 carry the human T-cell leukemia virus type I (HTLV-I). When MT-2 and MT-4 were infected with HTLV-III, the probable etiologic agent of the acquired immune deficiency syndrome (AIDS), rapid cytopathogenic effects and cytotoxicity were observed that made it possible to titrate the biologically active virus in a plaque-forming assay. The cytopathogenic effects were preceded by the rapid induction and increase of HTLV-III antigens as revealed by immunofluorescence and immunoprecipitation. Activities of HTLV-III were neutralized by the human antibodies against the virus when immunofluorescence and plaque assays were used. Essentially the same results were obtained with the lymphadenopathy-associated virus (LAV1).
No takes yet. Share an insight, caveat, or question.
Harada et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: